Loading organizations...
Loading organizations...
Biotechnology company developing RNA-based therapeutics.
Ribocure Pharmaceuticals has raised $120.0M across 1 funding round.
Ribocure Pharmaceuticals has raised $120.0M in total across 1 funding round.
Ribocure Pharmaceuticals has raised $120.0M in total across 1 funding round.
Ribocure Pharmaceuticals's investors include CDH Investments, China Renaissance.
Ribocure Pharmaceuticals has raised $120.0M across 1 funding round. Most recently, it raised $120.0M Series B in March 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 28, 2022 | $120.0M Series B | CDH Investments, China Renaissance |